1354223-46-3

Usage

Uses

Used in Organic Synthesis:
3-bromo-7-iodoquinoline is used as a synthetic intermediate for the preparation of various organic compounds. Its unique structure with bromine and iodine atoms at positions 3 and 7 allows for further chemical reactions and modifications, making it a valuable building block in the synthesis of complex molecules.
Used in Research and Scientific Experimentation:
3-bromo-7-iodoquinoline is used as a research compound for studying its chemical properties and potential applications in various fields. Its reactivity and structural features make it an interesting subject for exploration in academic and industrial research settings.
Used in Pharmaceutical Industry:
3-bromo-7-iodoquinoline is used as a potential candidate for the development of new drugs. Its unique structure and reactivity may offer opportunities for the creation of novel therapeutic agents, particularly in the areas of medicinal chemistry and drug discovery.
Used in Chemical Industry:
3-bromo-7-iodoquinoline is used as a raw material or intermediate in the production of various chemical products. Its versatility in chemical reactions and potential for modification make it a valuable component in the synthesis of a wide range of chemical compounds.

Upstream product

• 30450-62-5 7-nitro-1,2,3,4-tetrahydro-quinoline 
• 1344046-07-6 7-amino-3-bromoquinoline 
• 613-51-4 7-nitroquinoline 

Relevant academic research and scientific papers

HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS

The present disclosure describes novel heterocyclic PRMT5 inhibitors and methods for preparing them. The pharmaceutical compositions comprising such PRMT5 inhibitors and methods of using them for treating cancer, infectious diseases, and other PRMT5 associated disorders are also described.

HETEROCYCLIC COMPOUNDS AS PRMT5 INHIBITORS

The present disclosure describes novel PRMT5 inhibitors and methods for preparing them. The pharmaceutical compositions comprising such PRMT5 inhibitors and methods of using them for treating cancer, infectious diseases, and other PRMT5 associated disorde

NOVEL NICOTINAMIDE DERIVATIVES OR SALTS THEREOF

An object of the present invention is to provide to a compound and a pharmaceutical composition, which have excellent Syk-inhibitory activity. Th e present invention provides a nicotinamide derivative represented by the follo wing formula (I) (wherein R 1 represents a halogen atom; R 2 represents a C 1-12 alkyl group, a C 2-12 alkenyl group, a C 2-12 alkynyl group, a C 3-8 cycloalkyl g roup, an aryl group, an ar-C 1-6 alkyl group or a heterocyclic group, each opti onally having at least one substituent; R 3 represents an aryl group or a hetero cyclic group each optionally having at least one substituent; and R 4 and R 5 e ach independently represent a hydrogen atom; and R 2 and R 4 may form a cyc lic amino group optionally having at least one substituent together with the ni trogen atom to which they bind) or a salt thereof, and a pharmaceutical comp osition for use in the treatment of a Syk-related disease which comprises the nicotinamide derivative or a salt thereof.